Rallying MannKind Corporation (MNKD) Remains Plagued By Pessimism

MannKind Corporation (MNKD) is moving higher in spite of broad-market headwinds

by Andrea Kramer

Published on Jun 4, 2015 at 2:50 PM

While U.S. stocks -- and bonds -- are taking it on the chin in the wake of the latest Greek-debt developments, and ahead of a big economic day tomorrow, the shares of drugmaker MannKind Corporation (NASDAQ:MNKD) are up 6.6% at $5.90, in what some are attributing to a short squeeze. However, it looks like some options traders are rolling the dice on a short-term pullback. 

MNKD options are trading at 1.5 times the average intraday pace, with the now out-of-the-money August 5 put drawing the most attention. The International Securities Exchange (ISE) indicates that a healthy portion of the puts were bought to open at a volume-weighted average price (VWAP) of $0.98. As such, the buyers will make money if MNKD sinks beneath $4.02 (strike minus VWAP) by the close on Friday, Aug. 21, when the options expire.

Since touching a two-year low of $3.46 last month, the shares of MNKD have added nearly 71%. In fact, the stock is on pace to end the session atop its 200-day moving average for the first time since mid-February.

Nevertheless, bearish bets are par for the course for MNKD. On the ISE, Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), the security's 10-day put/call volume ratio of 1.73 stands higher than 99% of all other readings from the past year. In other words, option buyers have picked up MNKD puts over calls at a near-annual-high clip during the past two weeks.

As such, the stock's Schaeffer's put/call open interest ratio (SOIR) rests at 0.99 -- in the 97th percentile of its annual range. In simpler terms, near-term option players have rarely been more put-biased during the past 12 months.

And, as alluded to earlier, a short squeeze isn't outside the realm of possibility. Short interest represents a whopping 41.9% of MannKind Corporation's (NASDAQ:MNKD) total available float -- representing nearly three weeks' worth of pent-up buying demand, at the equity's average daily trading volume.


A Schaeffer's exclusive!

The Expert's Guide

Access your FREE trading earning announcements before it's too late!


  
 

Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


Research Exposes Shortcut to Stock Market Wins
A simple way to stop picking losers, and start cashing in like Wall Street's elite.
Cannabis Stock Rally Cut Short after Downgrade
Aurora Cannabis did receive a price-target hike from Jefferies, though
Vaccines, China Trigger Roller Coaster Week for Stocks
Moderna's vaccine captured the attention of Wall Street
Research Exposes Shortcut to Stock Market Wins
A simple way to stop picking losers, and start cashing in like Wall Street's elite.